Systemic antimicrobial therapy in skin and skin structure infections: Comparison of temafloxacin and ciprofloxacin
- 1 December 1991
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 91 (6) , S115-S119
- https://doi.org/10.1016/0002-9343(91)90322-o
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In vitro activity of temafloxacin against gram-positive cocci including methicillin-resistant Staphylococcus aureusThe American Journal of Medicine, 1991
- In vitro activity of temafloxacin against gram-negative bacteria: An overviewThe American Journal of Medicine, 1991
- Pharmacokinetics of temafloxacin in humans after single oral dosesAntimicrobial Agents and Chemotherapy, 1991
- Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structureThe American Journal of Medicine, 1989
- The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacinJournal of Antimicrobial Chemotherapy, 1989
- Ciprofloxacin versus Ceftazidime in Skin and Soft Tissue InfectionsJournal of Chemotherapy, 1989
- A Survey of Clinical Experience with Ciprofloxacin, a New Quinolone AntimicrobialThe Journal of Clinical Pharmacology, 1988
- Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1987
- Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infectionAntimicrobial Agents and Chemotherapy, 1987
- Overview of clinical experience with ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986